Robert N Eberhart, DO
Family Practice · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Eberhart’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$55,753
Medicare paid this office $55,753 for 480 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 202 | $20,934 | $102 |
| Short return visit (20+ min) | 153 | $12,944 | $77 |
| New patient visit (45+ min) | 70 | $8,303 | $119 |
| New patient visit (30+ min) | 65 | $5,797 | $89 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 12 | $1,677 | $140 |
See all 10 services
| Return visit (30+ min) | 202 | $20,934 | $102 |
| Short return visit (20+ min) | 153 | $12,944 | $77 |
| New patient visit (45+ min) | 70 | $8,303 | $119 |
| New patient visit (30+ min) | 65 | $5,797 | $89 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 12 | $1,677 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 24 | $389 | $16 |
| Injection of drug or substance under skin or into muscle | 18 | $237 | $12 |
| Automated urinalysis test | 47 | $106 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 14 | $13 | None |
Who their Medicare patients are
480 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 66% · Also on Medicaid 14% · Health risk score 0.95. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 59% · Diabetes 23% · Chronic kidney disease 22% · Depression 21% · Coronary heart disease 17% · Cancer 17% · COPD 11% · Atrial fibrillation 11% · Heart failure 10% · Stroke 7% · Dementia 4%.
The office billed $213,800, Medicare allowed $81,760 and paid $55,753; for 748 services of 37 kinds; $181 of it was for drugs given in the office and $55,572 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 480 | 748 | 74 | 0.95 | $213,800 | $55,753 |
| 2023 | 385 | 584 | 74 | 0.92 | $142,367 | $40,404 |
| 2022 | 239 | 409 | 76 | 0.84 | $95,588 | $30,682 |
| 2021 | 30 | 39 | 73 | 0.92 | $11,987 | $3,725 |
| 2020 | 20 | 27 | 70 | 0.95 | $4,230 | $1,698 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 161 | $17,553 | $108 |
| Short return visit (20+ min) | 189 | $14,365 | $74 |
| New patient visit (30+ min) | 14 | $941 | $67 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $855 | $50 |
| Automated urinalysis test | 51 | $114 | $2 |
2022: 8 services
| Return visit (30+ min) | 67 | $8,045 | $120 |
| Short return visit (20+ min) | 79 | $6,740 | $84 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 62 | $3,243 | $51 |
| New patient visit (30+ min) | 29 | $2,962 | $102 |
| Long return visit (40+ min) | 18 | $2,919 | $162 |
| Short return visit | 26 | $1,796 | $67 |
| New patient visit (15+ min) | 15 | $1,251 | $83 |
| Automated urinalysis test | 18 | $40 | $2 |
Medicaid work
$7,320 in 2022
Medicaid paid $7,320 for 188 billed services this clinician did in 2022, up to 76 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 157 | $6,138 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 19 | $720 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 12 | $462 |
| 2022 | 188 | 3 | 76 | $7,320 |
Drugs they prescribed that Part D paid
$5,890
Pharmacies billed $5,890 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 420) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
344 generic and fewer than 11 brand-name prescriptions · $5,890 in drug cost · 155 antibiotic prescriptions to 146 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 45 | $1,280 | $28 |
| Neomycin-Polymyxin-Hc | 11 | $639 | $58 |
| Diclofenac | 24 | $475 | $20 |
| Sulfamethoxazole-Trimethoprim | 52 | $192 | $4 |
| Ofloxacin | 16 | $185 | $11 |
See all 12 drugs
| Albuterol Sulfate Hfa | 45 | $1,280 | $28 |
| Neomycin-Polymyxin-Hc | 11 | $639 | $58 |
| Diclofenac | 24 | $475 | $20 |
| Sulfamethoxazole-Trimethoprim | 52 | $192 | $4 |
| Ofloxacin | 16 | $185 | $11 |
| Doxycycline Monohydrate | 17 | $165 | $10 |
| Cephalexin | 34 | $162 | $5 |
| Amoxicillin-Clavulanate Potass | 15 | $128 | $9 |
| Mupirocin | 18 | $114 | $6 |
| Triamcinolone Acetonide | 12 | $42 | $3 |
| Prednisone | 12 | $35 | $3 |
| Paxlovid | 17 | $0 | $0 |
Year by year
| 2024 | 420 | 334 | 0% (0) | None | $5,890 |
| 2023 | 385 | 273 | None | 11% | $5,921 |
| 2022 | 203 | 152 | None | None | $5,013 |
| 2021 | 87 | 45 | 0% (0) | None | $1,759 |
| 2020 | 41 | 25 | 0% (0) | None | $834 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Albuterol Sulfate Hfa | 42 | $1,178 | $28 |
| Diclofenac | 22 | $494 | $22 |
| Cephalexin | 41 | $308 | $8 |
| Ofloxacin | 18 | $301 | $17 |
| Amoxicillin-Clavulanate Potass | 21 | $239 | $11 |
| Sulfamethoxazole-Trimethoprim | 37 | $166 | $4 |
| Mupirocin | 22 | $164 | $7 |
| Azithromycin | 30 | $157 | $5 |
| Paxlovid (Eua) | 12 | $131 | $11 |
| Triamcinolone Acetonide | 13 | $107 | $8 |
| Fluconazole | 11 | $68 | $6 |
2022: 8 drugs
| Albuterol Sulfate Hfa | 20 | $541 | $27 |
| Diclofenac | 12 | $236 | $20 |
| Fluticasone Propionate | 13 | $154 | $12 |
| Cephalexin | 14 | $132 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $123 | $10 |
| Paxlovid (Eua) | 12 | $118 | $10 |
| Azithromycin | 17 | $102 | $6 |
| Sulfamethoxazole-Trimethoprim | 15 | $63 | $4 |
2021: 1 drug
| Azithromycin | 19 | $100 | $5 |
Professional record
- NPI
- 1235609348
- Licence
- CA 20A19252
- Trained
- Arizona College of Osteopathic Medicine Mid Western University, 2018
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-11-30
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.